🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Skin Testing

Found 0 matching trials

Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types

PHASE2

This study was a pilot, safety, and pharmacokinetic study of MB-102 versus ...

Status

Completed

Location

Riverside Clinical Research

Start Date

2016-05-11

Trial ID

NCT02772276

Treatments Being Tested

MB-102-- single dose of 4 µmol/kg MB-102-- single dose of 130 mg MB-102-single dose of 130 mg or 2 doses of 130 mg 12 hours apart MB-102-- two doses of 130 mg 24 hours apart Iohexol QuantumLeap Radiance Brilliance (1 or 2 sensors)Brilliance (2-part sensor)

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

This is a multicenter, randomized, parallel-group study comparing the outco...

Status

Completed

Location

California 1

Start Date

2018-05-03

Trial ID

NCT03547635

Treatments Being Tested

AMNIOEXCEL Plus Amniotic Membrane A Marketed Comparator Standard of Care

Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin Incision

PHASE4

Individually-tailored administration of the opioid analgesic component duri...

Status

Completed

Location

Multiple Locations

Start Date

2013-01

Trial ID

NCT02884310

Treatments Being Tested

Remifentanil adapted to SPI Remifentanil fixed

Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

PHASE3

In this study researchers want to study the potential skin reaction after r...

Status

Completed

Location

Multiple Locations

Start Date

2013-06-10

Trial ID

NCT04531813

Treatments Being Tested

Butenafine HCl 1% (BAY1896425)Positive Control-Sodium lauryl sulfate (SLS)Negative Control

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

Pulmonary arteriovenous malformations (PAVMs) are a rare vascular condition...

Status

Completed

Location

Hammersmith Hospital, Du Cane Rd

Start Date

2011-04

Trial ID

NCT02436213

Treatments Being Tested

Cardiopulmonary exercise test Blood test

Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch

PHASE1

This study is intended to produce information on the pharmacokinetic charac...

Status

Completed

Location

Swiss Pharma Contract

Start Date

2005-11-07

Trial ID

NCT03785613

Treatments Being Tested

Test Product T1: Buprenorphine patch (9 mg)Test Product T2: Buprenorphine patch (3.8 mg)Reference Product R: Transtec patch (20 mg)Matching placebo patch to T1 Matching placebo patch to T2 Matching placebo patch to R

Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

PHASE1

An investigation on the cumulative skin irritation potential of a newly dev...

Status

Completed

Location

IKP GmbH

Start Date

2005-05

Trial ID

NCT00967174

Treatments Being Tested

Nicotine Patch Placebo Patch SLS Comparator Patch

Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study

N/A

In this exploratory study, we assessed the efficacy of a cosmetic product i...

Status

Completed

Location

Skin Research Center

Start Date

2023-10-30

Trial ID

NCT07166497

Treatments Being Tested

Cosmetic product RV4660C CY0203

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

PHASE1

The study will be conducted in participants with type1 diabetes on insulin ...

Status

Completed

Location

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.

Start Date

2016-03

Trial ID

NCT02703350

Treatments Being Tested

LY900014 Insulin Lispro

Ultrasound Guided Radiofrequency Ablation of Proximal Greater Occipital Nerve in Primary Occipital Neuralgia

N/A

The International Headache Society (IHS) defines occipital neuralgia, as a ...

Status

Completed

Location

Mersin Training and Research Hospital

Start Date

2022-01-01

Trial ID

NCT06458179

Treatments Being Tested

Ultrasound-guided proximal greater occipital nerve radiofrequency ablation

Previous Next